Fact CheckerSign in

NCT06044051Recruiting

Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma

Dynamique Des Microbiomes Respiratoires Des Voies supérieures et inférieures associée à l'Asthme sévère Des Nourrissons

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

Nature of potential dysbiosis, interrelation of the different microbiomes of the respiratory tract, and potential role of the immune system in the pathogenesis of severe asthma in infants, and its evolution under treatment. Exploring and understanding these data is to improve patient care and discover new therapeutic targets. The aim is to open up prospects for therapeutic studies, such as the use of azithromycin as an immunomodulator in infant asthma, the results of which are discordant.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
27 Jul 2023
Start date
26 Sept 2023
Primary completion date
26 Sept 2026
Lead sponsor
University Hospital, Rouen
Diseases
Asthma
NCT number
NCT06044051

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 26 Sept 2023 to the primary completion date, 26 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Antibiotic therapy in progress or administered the seven days preceding the date of inclusion (day hospitalization)

Other illness

  • Congenital heart disease with significant left to right shunt
  • Chronic respiratory disease other than infant asthma (cystic fibrosis, bronchiolitis obliterans)

Other

  • Prematurity \<32 WA
  • Refusal of bronchial fibroscopy

Who the study is looking for

  • Infants less than 24 months old
  • Follow-up by a pneumo-pediatrician for severe asthma in infants
  • Requiring etiological investigations and assessment of severity in day hospitalization, including bronchial fibroscopy (HAS 2009)
  • Parent informed of the research and having signed consent

Age in the registry: - to 24 months · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rouen University Hospital
Coordinator of this site? Confirm its status
RouenFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.